Generative Co-Design of Antibody Sequences and Structures via Black-Box Guidance in a Shared Latent Space
By: Yinghua Yao, Yuangang Pan, Xixian Chen
Potential Business Impact:
Designs better medicines faster and cheaper.
Advancements in deep generative models have enabled the joint modeling of antibody sequence and structure, given the antigen-antibody complex as context. However, existing approaches for optimizing complementarity-determining regions (CDRs) to improve developability properties operate in the raw data space, leading to excessively costly evaluations due to the inefficient search process. To address this, we propose LatEnt blAck-box Design (LEAD), a sequence-structure co-design framework that optimizes both sequence and structure within their shared latent space. Optimizing shared latent codes can not only break through the limitations of existing methods, but also ensure synchronization of different modality designs. Particularly, we design a black-box guidance strategy to accommodate real-world scenarios where many property evaluators are non-differentiable. Experimental results demonstrate that our LEAD achieves superior optimization performance for both single and multi-property objectives. Notably, LEAD reduces query consumption by a half while surpassing baseline methods in property optimization. The code is available at https://github.com/EvaFlower/LatEnt-blAck-box-Design.
Similar Papers
Guided Sequence-Structure Generative Modeling for Iterative Antibody Optimization
Machine Learning (CS)
Designs better medicines faster using computer models.
Semi-supervised Latent Bayesian Optimization for Designing Antimicrobial Peptides
Machine Learning (CS)
Finds new germ-fighting medicines faster.
Learning from B Cell Evolution: Adaptive Multi-Expert Diffusion for Antibody Design via Online Optimization
Machine Learning (CS)
Designs better antibodies for specific sicknesses.